The efficacy and safety of Anyu Peibo Capsule in the treatment of patients with major depressive disorder in China: study protocol for a randomized placebo-controlled trial

BACKGROUND: Major depressive disorder is the second leading cause of years lost to disability worldwide. Anyu Peibo Capsule has been shown to be effective and safe in phase II trials. METHODS: This clinical study is a multi-center, randomized, double-blinded, placebo-controlled, parallel-group, phas...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jingjing, Yu, Yimin, Jiang, Yi, Chen, Wu, Li, Yan, Shen, Yifeng, Zheng, Qingshan, Li, Huafang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414707/
https://www.ncbi.nlm.nih.gov/pubmed/34479619
http://dx.doi.org/10.1186/s13063-021-05550-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414707/
https://www.ncbi.nlm.nih.gov/pubmed/34479619
http://dx.doi.org/10.1186/s13063-021-05550-9

Ejemplares similares